McGrane Ashley sold $9K of GTM

McGrane Ashley (General Counsel and Corp Sec) sold 2,461 shares of ZoomInfo Technologies Inc. (GTM) at $3.75 on 2026-10-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · McGrane Ashley
Published Oct 5, 2026, 8:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$GTM
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The disclosed sale is small and unlikely to move the stock, but it provides transparency for compliance monitoring.

02

Market read

A routine insider sale with minimal market impact; primarily of interest to compliance and monitoring teams.

03

What to watch

Potential tax‑loss harvesting or pre‑planned liquidity needs under the 10b5‑1 plan.

Relevance 2/10Novelty 2/10Timing: after‑hours filing on Oct 5

Background

Form 4 filings disclose insider transactions; a 10b5‑1 plan indicates pre‑arranged sales, often minimizing informational advantage.

Market effects

None significant; insider activity does not alter sector dynamics.

No regional effect.

Low; limited to ZoomInfo investors.

Counterpoint

The sale may be viewed as a routine portfolio rebalancing, not a negative signal.

Key entities

  • ZoomInfo Technologies Inc.

    Provider of go‑to‑market intelligence platforms, ticker ZI.

  • Ashley McGrane

    General Counsel and Corporate Secretary of ZoomInfo.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GTMMed

GTM Q2 Deep Dive: Upmarket Focus and Hybrid Pricing Strategy Take Center Stage

ZoomInfo (NASDAQ:GTM) reported Q2 CY2026 revenue of $310.4 million, up 1.2% year over year, beating expectations. Midpoint Q3 revenue guidance was $299.5 million, 1.6% above estimates. Non-GAAP EPS was $0.28, 5.8% above consensus. Management cited upmarket growth, 20% growth in its operations/data business, and a transition to hybrid consumption-based pricing plus AI products like GTM.AI.

$GTMMed

Year Outlook Slightly Exceeds Expectations

ZoomInfo (NASDAQ: GTM) reported Q2 CY2026 revenue of $310.4 million, up 1.2% year on year, beating Wall Street expectations. Next-quarter revenue guidance had a $299.5 million midpoint, 1.6% above estimates. Non-GAAP EPS was $0.28, 5.8% above consensus. The article also cites billings of $295.8 million and 1,891 enterprise customers.

$GTMHigh

ZoomInfo Announces Second Quarter 2026 Financial Results

ZoomInfo Technologies Inc. (GTM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ZoomInfo Announces Second Quarter 2026 Financial Results VANCOUVER, Wash. , August 5, 2026 - ZoomInfo (NASDAQ: GTM), the all-in-one AI GTM platform, today announced its financial results for the second quarter ended June 30, 2026. “Our native MCP integrations with An

$GTMMedAI 8/10

ZoomInfo (GTM) Launches Native App Inside OpenAI Codex for Work

ZoomInfo said OpenAI made ZoomInfo natively available inside OpenAI Codex for Work, a B2B data and go-to-market intelligence app. ZoomInfo stated OpenAI selected it to bring verified company intelligence, contacts, and go-to-market signals into Codex so users can run its skills via natural language. Separately, analysts at Morgan Stanley and JPMorgan cut price targets after lower free cash flow and fiscal 2026 outlook.

$GTMMedAI 9/10

Is ZoomInfo Technologies Inc. (GTM) One of the Best Tech Stocks Under $5 to Buy?

Jefferies downgraded ZoomInfo (GTM) to Hold from Buy on May 21, cutting its price target to $4 from $12 and citing a “material” reduction in projected 2026 revenue growth plus no improvement expected in 2027. The firm said client demand has been weak for two years and AI is changing purchasing behavior. Morgan Stanley on May 19 cut its target to $5 from $9, keeping Equal Weight.